New from CDC: 2022 National and State Healthcare-Associated Infections Progress Report

crossorigin="anonymous">Explore current data

2022 National and State Healthcare-Associated Infections (HAI) Progress Report Shows Improvements in Preventing HAIs in Acute Care Hospitals

CDC has released the 2022 National and State Healthcare-Associated Infections (HAI) Progress Report, which shows progress in preventing several important HAIs in acute care hospitals (ACHs). This is the first HAI Progress Report to show decreases in HAIs since the emergence of the COVID-19 pandemic in 2020. This is a notable accomplishment for ACHs, given the ongoing challenges healthcare facilities continue to manage.    Decreases in the standardized infection ratio (SIR)* from 2021 to 2022 for some HAIs in ACHs included: 19% decrease in ventilator-associated events (VAE) 16% decrease in hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia 12% decrease in catheter-associated urinary tract infections (CAUTI) 9% decrease in central line-associated bloodstream infections (CLABSI) 3% decrease in hospital-onset Clostridioides difficile infection (CDI) 2022 National HAI SIRs compared to 2021 SIRs by Facility Setting

The report includes data submitted to CDC’s National Healthcare Safety Network (NHSN) across four healthcare settings: ACHs, critical access hospitals (CAHs), inpatient rehabilitation facilities (IRFs) and long-term acute care hospitals (LTACHs). The report showed little progress in reducing HAIs in other healthcare settings. Among IRFs, there was a 9% decrease in hospital-onset CDI infection, otherwise there were no significant changes in the 2022 SIRs compared with 2021. Among LTACHs, there were no significant changes in 2022 SIRs compared with 2021. The 2022 National and State HAI Progress Report highlights the need for healthcare providers to continue to: Reinforce infection prevention and control practices in their facilities. Regularly review HAI surveillance data to identify areas that need to be improved. Address any gaps in prevention practices. CDC remains committed to protecting patients and promoting safety and quality in health care. CDC will continue partnering with healthcare facilities and other federal and local public health agencies to strengthen healthcare quality and improve patient safety across the United States. Read the full 2022 HAI Progress Report, including the executive summary, data tables, technical appendix, and frequently asked questions. Data for the HAI Progress Report are also available in CDC’s Antimicrobial Resistance & Patient Safety Portal (AR&PSP), an interactive web-based application that shows data collected through CDC’s NHSN and other sources.

*The Standardized Infection Ratio (SIR) is a summary statistic used to track HAI prevention progress over time; lower SIRs are better. The SIR compares the number of infections in a facility or state to the number of infections that were predicted, based on previous years of reported data.

	New 2022 National and State HAI Progress Report from @CDCgov shows decreases in healthcare-associated infections between 2021 and 2022 in acute care hospitals. Explore current data in the Antimicrobial Resistance & Patient Safety Portal: https://bit.ly/3QWb7cS #InfectionControl

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

Keep the momentum going to combat antimicrobial resistance

Our work to improve prescribing and use doesn’t stop here

The Mission Continues: What Are You Doing to Improve Antibiotic and Antifungal Use?

Thank you for supporting U.S. Antibiotic Awareness Week (USAAW). Even though USAAW just ended, our work to improve antibiotic and antifungal prescribing and use doesn’t stop here. We need your help to keep the momentum going!  Why it matters.   CDC recently published a paper showing clinician antibiotic prescribing behavior varies by patient’s race and ethnicity, sex, age, socioeconomic factors, geography, clinician’s age and specialty, and healthcare setting.  CDC is prioritizing reducing health inequities. Health inequities resulting from less-than-optimal antibiotic or antifungal prescribing practices may impact health outcomes. More research is needed to fully understand potential disparities related to antimicrobial resistance (AR), so we can take further action to reduce the impact AR has on our health.

Antimicrobial-resistant infections are one of the biggest public health challenges of our time. Each year in the United States, at least 2.8 million people get an antimicrobial-resistant infection, and more than 35,000 people die.  Any time antibiotic and antifungal drugs are used to treat an infection, they can cause side effects and contribute to the development of AR.  Antimicrobial resistance has been identified in all regions of the world and can rapidly spread. Factors such as access to clean water and adequate sanitation, vaccination coverage, and access to quality health care can impact the spread of antimicrobial resistance and the number of infections worldwide.

From travelers, animal owners, and caregivers to patients and healthcare providers, we all have a role to play to combat antimicrobial resistance.  What can you do with your family to reduce your risk of infections and combat antimicrobial resistance?   Ask your healthcare provider or veterinarian about the best treatment when you, your family, or an animal is sick. Antibiotics and antifungals aren’t always the answer.  Keep your hands clean by washing or using hand sanitizer with at least 60% alcohol to help stop germs from spreading.  Stay up to date on recommended vaccines to help prevent infections, slow antimicrobial resistance, and reduce antibiotic and antifungal use.  Prepare food safely to avoid foodborne infections. Clean your hands, utensils, and surfaces. Separate raw meat from other foods. Cook foods to safe temperatures. Chill foods promptly.  Choose safer sexual activities and use condoms the right way from start to finish to lower your risk of getting a drug-resistant sexually transmitted infection.  What can healthcare providers do to improve antibiotic or antifungal use and prescribing and reduce infections to combat antimicrobial resistance?  Follow infection prevention and control guidelines, including screening at-risk patients when indicated.  Improve antibiotic and antifungal prescribing by following clinical and treatment guidelines.  Educate patients on ways to prevent spread of germs and infections.  Be aware of infections and AR trends in your facility and community.  Inform patients and families if they have an antimicrobial-resistant infection, as well as sexual partners when appropriate.  Know when to report cases and submit resistant isolates to the health department to identify unusual resistance or treatment failures.  Ensure your patients receive recommended vaccines.  Talk to your patients and their families about preventing infections, keeping scrapes and wounds clean, managing chronic conditions, seeking medical care when an infection is not getting better, and understanding when antibiotics and antifungals are needed. Check out some of the resources we shared during USAAW!   Heath Equity and Antimicrobial Resistance article and factsheet.  Be Antibiotics Aware educational materials for patients/families and healthcare professionals. You can order FREE print resources by calling 1-800-CDC-INFO or visiting CDC Publications on Demand. Select “Antibiotic Use” from the Program drop-down menu and click “Apply” to view all available publications.  Antibiotic Stewardship Resource Bundles for healthcare professionals, partner organizations, health departments, and professional societies.  New Safe Healthcare blogs on infection control practices in Ethiopia, antibiotic allergy stewardship, and supporting Argentina’s new antimicrobial resistance law.   Thank you, again, for participating in this important week. We look forward to continuing this important work with you to raise awareness about appropriate antibiotic and antifungal prescribing and use, and the threat of antimicrobial resistance. Together, we can combat antimicrobial resistance.

	Even though U.S. Antibiotic Awareness Week just ended, our work to improve #antibiotic and #antifungal prescribing/use. We all have a role to play to combat antimicrobial resistance. https://www.cdc.gov/DrugResistance/actions-to-fight.html

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

2024 Recommended Immunization Schedules Now LIVE - 11/16/2023

2024 Recommended Immunization Schedules Now Online

The 2024 ACIP Recommended Immunization Schedules were posted online today. As a reminder, the schedules summarize final recommendations that were previously adopted and made official by the CDC director. Therefore, these schedules are effective immediately.   **Earlier availability of the 2024 Immunization Schedules is part of CDC’s efforts to better support immunization professionals and improve timely implementation of new recommendations.       Schedule Changes & Guidance

Schedule changes are reflected in CDC’s healthcare provider web content as well as on the Immunization Schedule App.   The new schedules include October 2023 recommendations for use of Mpox and pentavalent meningococcal vaccine and updated recommendations for the following vaccines: COVID-19 RSV Influenza

	2024 Recommended Immunization Schedules

Child and Adolescent Schedule		Adult Schedule

Coming in Early 2024

		Updates to online vaccine assessment tools

		Updates to parent friendly schedules

		MMWRs summarizing the 2024 updates

Syndicate the 2024 Recommended Immunization Schedules on your Website   Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

World Antimicrobial Resistance Awareness Week Starts Soon

Get involved and help spread the word

World Antimicrobial Resistance Awareness Week 2023

Antimicrobial resistance (AR or AMR) is a global public health threat. AR has been identified in all regions of the world and can rapidly spread if no actions are taken. Factors such as access to antibiotics and antifungals, clean water and adequate sanitation, vaccination, and quality health care can impact the number of antimicrobial-resistant infections and deaths worldwide. CDC works with partners around the world to help countries improve their capacity to identify and combat AR in healthcare settings so that antimicrobial-resistant germs do not spread within hospitals, to communities, or across international borders. This World Antimicrobial Resistance Awareness Week (November 18 – 24), learn how CDC and partners are working together to detect, contain, and respond to AR. Scroll down to read about CDC work with global partners to combat AR and find out how you can get involved.

	Combating AR in Argentina: Legislation for the Future

Argentina’s Ministry of Health is implementing the first law in South America that uses a One Health framework to combat AR. This law lays out Argentina’s National Action Plan for the Prevention and Control of AR. Collaborative efforts, such as Argentina’s participation in CDC’s Global Action in Healthcare Network, are helping advance the implementation of the National Action Plan. Read the latest Safe Healthcare Blog to learn more.

	Defining Access Without Excess as New Antibiotics Become Available

New, potentially life-saving antibiotics have recently become available with improved ability to treat antimicrobial-resistant infections. Ensuring global access to these medications is crucial. However, taking steps to optimize their use is also critically important because inappropriate use could lead to them becoming less effective sooner. A new article in The Lancet from CDC authors, in collaboration with the World Health Organization (WHO), defines access without excess. The article emphasizes that expanded global access to new antibiotics should be balanced with strengthening antibiotic stewardship and diagnostics capacity to prevent excess use.

	Guide for Antibiotic Stewardship in Resource-limited Settings Now Available in Spanish

CDC’s Core Elements of Human Antibiotic Stewardship Programs in Resource-limited Settings is now available in Spanish. The Core Elements is a guide for implementing antibiotic stewardship programs in global, resource-limited settings with healthcare systems that lack robust regulatory frameworks. The guide contains practical, high-impact strategies based on both expert opinion and experiences in implementing antibiotic stewardship programs at national- and facility-levels to improve antibiotic use and fight AR.

	Context-Specific Tools for Assessing Antibiotic Stewardship Programs

CDC and partners have worked to develop and implement an assessment tool for antibiotic stewardship (AMS) programs at healthcare facilities that takes regional context into consideration. This tool was developed to complement the existing WHO AMS national assessment tool. With CDC support, Oxford University Clinical Research Unit collaborators implemented both WHO national and CDC healthcare facility AMS assessment tools in Indonesia, Nepal, Thailand, and Vietnam. Learn more about the tools and see assessment results.

	Clinical Infectious Diseases Supplement Provides Much-Needed Data on AR in Low- and Middle-Income Countries

Have you had the chance to check out July’s Clinical Infectious Diseases supplement, The Evolving Challenges of Antibiotic Resistance in Low- and Middle-Income Countries: Priorities and Solutions? Data on AR from low- and middle-income countries (LMICs) are sparse. This CDC-supported supplement helps fill the gaps, providing data on AR and antibiotic use from communities and hospitals across several LMICs. Learn more about the findings included in the supplement that highlight the critical need for a global effort to combat the spread of AR.

	Get Involved with WAAW

	Access Tools and Materials

	Now available: Check out WHO’s WAAW web page to download their 2023 campaign guide and materials and to see a calendar of their highlighted events. Now available: Access CDC’s U.S. Antibiotics Awareness Week (USAAW) 2023 Partner Toolkit to find key messages and social media graphics. Check out CDC’s Be Antibiotics Aware Partner Toolkit for antibiotic stewardship resources for human health.

	Engage in Social Media

November 16, 10 a.m.-11 a.m. EST: Join CDC’s Global X (formally Twitter) Storm. Participants will raise awareness of AR by posting about AR and One Health during the designated time using hashtag #WAAW23Xstorm. If your organization would like to participate, contact us at IICB@cdc.gov for more details. November 18-24, daily: Help spread the word with family, friends, and colleagues so they can also get involved. Follow @CDC_AR and repost throughout the week using #AntimicrobialResistance and #WAAW. November 24, 12 a.m.-11:59 p.m. CET: Join AMR Insights’ AMRelay 2023, a 24-hour online event offering a series of 96 consecutive contributions by global stakeholders involved in curbing antimicrobial resistance.

	Attend Conferences and Webinars

November 16-17: Emerging Antimicrobials and Diagnostics in Antimicrobial Resistance 2023 in Amsterdam, the Netherlands provides the opportunity to catch up with global AR research and development, develop new collaborations, and accelerate AR innovations. November 20, 9 a.m. EST: The Global Subcommittee of the Pediatric Committee on Antimicrobial Stewardship (Pediatric Infectious Diseases Society), in collaboration with WHO, is hosting a webinar on Global AR Surveillance and Pediatric Considerations. November 21, 7-8:30 a.m. EST: The International Pharmaceutical Federation is hosting a webinar on the Management of Fungal Diseases, Antifungal Stewardship, and the Role of Pharmacists. November 21, 4-5:30 p.m. CET: The WHO Taskforce of Antimicrobial Resistance Survivors is hosting a webinar to bring together survivors of antimicrobial-resistant infections for a sharing of experiences and perspectives on the vital role that survivors’ accounts can play in enhancing and expanding AR awareness-raising and advocacy activities.

Select WAAW partner activities will be highlighted in the December edition of CDC’s International Infection Control Branch (IICB) newsletter. Let us know how your organization is celebrating WAAW by emailing us at IICB@cdc.gov.

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe